Accor: a satisfactory publication according to UBS.
(CercleFinance.com) - UBS has confirmed its buy rating on the Accor stock, after the hotel group reported its Q3 sales last night.
The broker has also confirmed its 12-month target price of 45.25 euros.
Q3 sales came in at 504 million euros, exceeding UBS' expectations (482 million euros), which is also true for organic growth (6.4% vs. 5.7%).
"3Q group revpar was 4.5% (UBS 5%) with France/Swiss up 5%, Europe revpar up c8% (...) and Asia-Pac c4% in Asia Pacific," says UBS. The trend remains negative in South America (-12%), but it is improving, with stabilisation in Brazil.
Copyright (c) 2017 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
The broker has also confirmed its 12-month target price of 45.25 euros.
Q3 sales came in at 504 million euros, exceeding UBS' expectations (482 million euros), which is also true for organic growth (6.4% vs. 5.7%).
"3Q group revpar was 4.5% (UBS 5%) with France/Swiss up 5%, Europe revpar up c8% (...) and Asia-Pac c4% in Asia Pacific," says UBS. The trend remains negative in South America (-12%), but it is improving, with stabilisation in Brazil.
Copyright (c) 2017 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.